AstraZeneca PLC. The Group's principal activity is discovering, developing, manufacturing and marketing prescription pharmaceuticals and biological products. The Group's operation focuses on six therapeutic areas namely, Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation. Products include Crestor, ... More

AstraZeneca PLC. The Group's principal activity is discovering, developing, manufacturing and marketing prescription pharmaceuticals and biological products. The Group's operation focuses on six therapeutic areas namely, Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation. Products include Crestor, Atacand, Selok/Toprol-XL, Zestril, Nexium, Losec/Prilosec, Entocort, Synagis, FluMist, Seroquel, Diprivan, Naropin, Xylocaine, Arimidex, Zoladex, Iressa, Faslodex, Nolvadex, Abraxane, Symbicort Turbuhaler, Pulmicort, Rhinocort and Accolate. The Group operates in the United Kingdom, Belgium, France, Germany, Italy, Spain, Sweden, the Netherlands, Canada, Puerto Rico, the Cayman Islands, the United States of America, Australia and Japan.